{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T02:11:44Z","timestamp":1776651104813,"version":"3.51.2"},"reference-count":72,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.rdc.2025.07.004","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T14:52:34Z","timestamp":1757083954000},"page":"577-594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic Evaluation for Myositis and Their Pitfalls"],"prefix":"10.1016","volume":"51","author":[{"given":"Takeshi","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jemima","family":"Albayda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rdc.2025.07.004_bib1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat Rev Dis Primer"},{"issue":"9","key":"10.1016\/j.rdc.2025.07.004_bib2","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and management of adult inflammatory myopathies","volume":"17","author":"Selva-O\u2019Callaghan","year":"2018","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.rdc.2025.07.004_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","article-title":"A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy","volume":"52","author":"Satoh","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"10.1016\/j.rdc.2025.07.004_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s13317-014-0063-1","article-title":"Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation","volume":"5","author":"Iaccarino","year":"2014","journal-title":"Auto-Immun Highlights"},{"issue":"11","key":"10.1016\/j.rdc.2025.07.004_bib5","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/rheumatology\/40.11.1262","article-title":"Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies","volume":"40","author":"Miller","year":"2001","journal-title":"Rheumatol Oxf Engl"},{"issue":"33","key":"10.1016\/j.rdc.2025.07.004_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004344","article-title":"Creatine kinase in the U.S. population: impact of demographics, comorbidities, and body composition on the normal range","volume":"95","author":"George","year":"2016","journal-title":"Medicine (Baltim)"},{"issue":"4","key":"10.1016\/j.rdc.2025.07.004_bib7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ahj.2007.06.008","article-title":"Distribution of creatine kinase in the general population: implications for statin therapy","volume":"154","author":"Brewster","year":"2007","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.rdc.2025.07.004_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16117","article-title":"Disease spectrum of myopathies with elevated aldolase and normal creatine kinase","volume":"31","author":"Soontrapa","year":"2024","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.rdc.2025.07.004_bib10","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1016\/S2665-9913(23)00322-3","article-title":"Idiopathic inflammatory myopathies: current insights and future frontiers","volume":"6","author":"Connolly","year":"2024","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2025.07.004_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/1744666X.2019.1699059","article-title":"Current understanding and recent advances in myositis-specific and -associated autoantibodies detected in patients with dermatomyositis","volume":"16","author":"Gono","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"issue":"11","key":"10.1016\/j.rdc.2025.07.004_bib12","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1136\/ard-2024-225773","article-title":"Pathological autoantibody internalisation in myositis","volume":"83","author":"Pinal-Fernandez","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.rdc.2025.07.004_bib13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrrheum.2018.56","article-title":"Autoantibodies in myositis","volume":"14","author":"McHugh","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2025.07.004_bib14","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jamadermatol.2016.1429","article-title":"Ovoid palatal patch; a novel finding in dermatomyositis associated with anti-TIF1-\u03b3 (p155) antibodies","volume":"152","author":"Bernet","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.rdc.2025.07.004_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41584-023-01054-9","article-title":"Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress","volume":"20","author":"Lu","year":"2024","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2025.07.004_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.rdc.2025.07.004_bib17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nmd.2019.10.005","article-title":"239th ENMC international workshop: classification of dermatomyositis, Amsterdam, The Netherlands, 14-16 December 2018","volume":"30","author":"Mammen","year":"2020","journal-title":"Neuromuscul Disord NMD"},{"key":"10.1016\/j.rdc.2025.07.004_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2024.104453","article-title":"273rd ENMC international workshop: clinico-sero-morphological classification of the antisynthetase syndrome. Amsterdam, The Netherlands, 27-29 October 2023","volume":"45","author":"Stenzel","year":"2024","journal-title":"Neuromuscul Disord NMD"},{"issue":"4","key":"10.1016\/j.rdc.2025.07.004_bib19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.rdc.2025.07.004_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.745211","article-title":"Clinical value of 18F-FDG PET\/CT scan and cytokine profiles in secondary hemophagocytic lymphohistiocytosis in idiopathic inflammatory myopathy patients: a pilot study","volume":"12","author":"Liang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.rdc.2025.07.004_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keae167","article-title":"Assessing the sensitivity and specificity of myositis-specific and associated autoantibodies: a sub-study from the MyoCite cohort","author":"Loganathan","year":"2024","journal-title":"Rheumatol Oxf Engl"},{"issue":"7","key":"10.1016\/j.rdc.2025.07.004_bib21","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.autrev.2019.05.002","article-title":"Anti-OJ autoantibodies: rare or underdetected?","volume":"18","author":"Vulsteke","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.rdc.2025.07.004_bib22","first-page":"277","article-title":"Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank","volume":"42","author":"Loganathan","year":"2024","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2025.07.004_bib23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.41088","article-title":"Myositis autoantibodies: a comparison of results from the Oklahoma medical research foundation myositis panel to the euroimmun research line blot","volume":"72","author":"Mecoli","year":"2020","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"4","key":"10.1016\/j.rdc.2025.07.004_bib24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.rdc.2024.07.005","article-title":"Imaging modalities in myositis: a clinical review","volume":"50","author":"Yoshida","year":"2024","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"10.1016\/j.rdc.2025.07.004_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00256-023-04367-8","article-title":"Society of skeletal radiology position paper - recommendations for contrast use in musculoskeletal MRI: when is non-contrast imaging enough?","volume":"53","author":"Samet","year":"2024","journal-title":"Skeletal Radiol"},{"issue":"10","key":"10.1016\/j.rdc.2025.07.004_bib26","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.nmd.2023.08.014","volume":"33","author":"de Visser","year":"2023","journal-title":"Neuromuscul Disord NMD"},{"issue":"5","key":"10.1016\/j.rdc.2025.07.004_bib27","first-page":"74","article-title":"The role of imaging in evaluating patients with idiopathic inflammatory myopathies","volume":"36 Suppl 114","author":"Kub\u00ednov\u00e1","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2025.07.004_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2022.101765","article-title":"Muscle imaging in myositis: MRI, US, and PET","volume":"36","author":"Albayda","year":"2022","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2025.07.004_bib29","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.semarthrit.2016.11.001","article-title":"The role of magnetic resonance imaging techniques in evaluation and management of the idiopathic inflammatory myopathies","volume":"46","author":"Day","year":"2017","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2025.07.004_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000850","article-title":"MRI of skeletal muscles in patients with idiopathic inflammatory myopathies: characteristic findings and diagnostic performance in dermatomyositis","volume":"5","author":"Ukichi","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.rdc.2025.07.004_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13075-017-1219-y","article-title":"Comparative analyses of muscle MRI and muscular function in anti-synthetase syndrome patients and matched controls: a cross-sectional study","volume":"19","author":"Andersson","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.rdc.2025.07.004_bib32","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/annrheumdis-2012-202915","article-title":"Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis","volume":"73","author":"Malattia","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2025.07.004_bib33","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/annrheumdis-2016-210198","article-title":"Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity","volume":"76","author":"Pinal-Fernandez","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2025.07.004_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/mus.24661","article-title":"MRI pattern recognition in sporadic Inclusion Body Myositis","volume":"52","author":"Tasca","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.rdc.2025.07.004_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1146015","article-title":"Imaging biomarkers in the idiopathic inflammatory myopathies","volume":"14","author":"Zubair","year":"2023","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.rdc.2025.07.004_bib36","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/mus.27142","article-title":"Diagnostic usefulness of denervation edema in the multifidus muscles using 3-Tesla magnetic resonance imaging in cervical radiculopathy","volume":"63","author":"Yoshida","year":"2021","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1016\/j.rdc.2025.07.004_bib37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11926-020-00947-y","article-title":"Diagnostic value of muscle ultrasound for myopathies and myositis","volume":"22","author":"Albayda","year":"2020","journal-title":"Curr Rheumatol Rep"},{"issue":"7","key":"10.1016\/j.rdc.2025.07.004_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/1756-185X.15257","article-title":"Usefulness of skeletal muscle ultrasound as a screening test for sarcopenia in patients with rheumatoid arthritis","volume":"27","author":"Yoshida","year":"2024","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.rdc.2025.07.004_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/mus.27833","article-title":"Correlation of muscle ultrasound with clinical and pathological findings in idiopathic inflammatory myopathies","volume":"68","author":"Yoshida","year":"2023","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.rdc.2025.07.004_bib40","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/mr\/roab049","article-title":"Ultrasound assessment of sarcopenia in patients with rheumatoid arthritis","volume":"32","author":"Yoshida","year":"2022","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2025.07.004_bib41","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/rheumatology\/keac263","article-title":"Ultrasound and MR muscle imaging in new onset idiopathic inflammatory myopathies at diagnosis and after treatment: a comparative pilot study","volume":"62","author":"Walter","year":"2023","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.rdc.2025.07.004_bib42","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/mus.27081","article-title":"Muscle ultrasound: present state and future opportunities","volume":"63","author":"Wijntjes","year":"2021","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.rdc.2025.07.004_bib43","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0022-3476(82)80286-2","article-title":"Ultrasound imaging in the diagnosis of muscle disease","volume":"101","author":"Heckmatt","year":"1982","journal-title":"J Pediatr"},{"key":"10.1016\/j.rdc.2025.07.004_bib44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.nmd.2024.07.001","article-title":"Improving Heckmatt muscle ultrasound grading scale through Rasch analysis","volume":"42","author":"Wijntjes","year":"2024","journal-title":"Neuromuscul Disord NMD"},{"key":"10.1016\/j.rdc.2025.07.004_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2025.102055","article-title":"Practical utilization of sonography for the assessment of muscle diseases in rheumatology","author":"Yoshida","year":"2025","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2025.07.004_bib46","doi-asserted-by":"crossref","first-page":"e006763","DOI":"10.1136\/bmjopen-2014-006763","article-title":"Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: imaging of skeletal muscle inflammation","volume":"5","author":"Tateyama","year":"2015","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.rdc.2025.07.004_bib47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s42466-022-00213-9","article-title":"PET-MRI in idiopathic inflammatory myositis: a comparative study of clinical and immunological markers with imaging findings","volume":"4","author":"Girija","year":"2022","journal-title":"Neurol Res Pract"},{"issue":"11","key":"10.1016\/j.rdc.2025.07.004_bib48","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11926-019-0864-3","article-title":"PET scan: nuclear medicine imaging in myositis","volume":"21","author":"Selva-O\u2019Callaghan","year":"2019","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.rdc.2025.07.004_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.779272","article-title":"Radiological characteristics of patients with anti-MDA5\u2013antibody-positive dermatomyositis in 18F-FDG PET\/CT: a pilot study","volume":"8","author":"Cao","year":"2021","journal-title":"Front Med"},{"issue":"7","key":"10.1016\/j.rdc.2025.07.004_bib51","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/rheumatology\/keae029","article-title":"Advances in the diagnosis of myocarditis in idiopathic inflammatory myopathies: an overview of diagnostic tests","volume":"63","author":"Sen","year":"2024","journal-title":"Rheumatol Oxf Engl"},{"issue":"15","key":"10.1016\/j.rdc.2025.07.004_bib52","first-page":"1132","article-title":"Cardiac sarcoidosis","volume":"109","author":"Sohn","year":"2023","journal-title":"Heart Br Card Soc"},{"issue":"6","key":"10.1016\/j.rdc.2025.07.004_bib53","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1007\/s00259-020-05185-z","article-title":"[68Ga]Ga-FAPI and [18F]FDG PET\/CT images in a patient with juvenile polymyositis","volume":"48","author":"Zheng","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.rdc.2025.07.004_bib54","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/RLU.0000000000003809","article-title":"Dermatomyositis on 68Ga-FAPI PET\/CT in a patient with nasopharyngeal carcinoma","volume":"47","author":"Wu","year":"2022","journal-title":"Clin Nucl Med"},{"issue":"9","key":"10.1016\/j.rdc.2025.07.004_bib55","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/jnnp.2009.197640","article-title":"Increased [11C]PIB-PET levels in inclusion body myositis are indicative of amyloid beta deposition","volume":"82","author":"Maetzler","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.rdc.2025.07.004_bib56","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/annrheumdis-2018-214644","article-title":"[18F]Florbetapir positron emission tomography: identification of muscle amyloid in inclusion body myositis and differentiation from polymyositis","volume":"78","author":"Lilleker","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.rdc.2025.07.004_bib57","doi-asserted-by":"crossref","first-page":"e1158","DOI":"10.1212\/WNL.0000000000207596","article-title":"Imaging with PET\/CT of diffuse CD8 T-cell infiltration of skeletal muscle in patients with inclusion body myositis","volume":"101","author":"Quinn","year":"2023","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.rdc.2025.07.004_bib58","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s13244-014-0349-x","article-title":"FDG-PET\/CT pitfalls in oncological head and neck imaging","volume":"5","author":"Purohit","year":"2014","journal-title":"Insights Imaging"},{"issue":"8","key":"10.1016\/j.rdc.2025.07.004_bib59","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s11604-022-01264-3","article-title":"Atlas of non-pathological solitary or asymmetrical skeletal muscle uptake in [18F]FDG-PET","volume":"40","author":"Yamane","year":"2022","journal-title":"Jpn J Radiol"},{"issue":"6","key":"10.1016\/j.rdc.2025.07.004_bib60","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/rpd\/ncad040","article-title":"Cancer risk estimation for patients undergoing whole-body PET\/CT scans","volume":"199","author":"Kessara","year":"2023","journal-title":"Radiat Prot Dosimetry"},{"issue":"12","key":"10.1016\/j.rdc.2025.07.004_bib61","article-title":"International guideline for idiopathic inflammatory myopathy-associated cancer screening: an international myositis assessment and clinical studies group (IMACS) initiative","volume":"19","author":"Ags","year":"2023","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2025.07.004_bib62","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mus.26381","article-title":"Needle electromyography and histopathologic correlation in myopathies","volume":"59","author":"Sener","year":"2019","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.rdc.2025.07.004_bib63","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/mus.21180","article-title":"Needle electromyography","volume":"39","author":"Daube","year":"2009","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.rdc.2025.07.004_bib64","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000037105","article-title":"Frequency of EMG abnormalities in idiopathic inflammatory myopathies under the EULAR\/ACR classification criteria","volume":"103","author":"Hokkoku","year":"2024","journal-title":"Medicine (Baltim)"},{"issue":"2","key":"10.1016\/j.rdc.2025.07.004_bib65","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00004691-199304000-00002","article-title":"The electrodiagnostic examination with myopathies","volume":"10","author":"Wilbourn","year":"1993","journal-title":"J Clin Neurophysiol"},{"issue":"10","key":"10.1016\/j.rdc.2025.07.004_bib66","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/mus.880131010","article-title":"Electrophysiological spectrum of inclusion body myositis","volume":"13","author":"Joy","year":"1990","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.rdc.2025.07.004_bib67","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/01.cnd.0000157370.32983.53","article-title":"The electromyographic features of acute rhabdomyolysis","volume":"6","author":"Al-Shekhlee","year":"2005","journal-title":"J Clin Neuromuscul Dis"},{"issue":"2","key":"10.1016\/j.rdc.2025.07.004_bib68","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12020-017-1472-5","article-title":"Diagnostic work-up in steroid myopathy","volume":"60","author":"Minetto","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.rdc.2025.07.004_bib69","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nmd.2024.03.001","article-title":"272nd ENMC international workshop: 10 Years of progress - revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16-18 June 2023, Hoofddorp, The Netherlands","volume":"37","author":"Lilleker","year":"2024","journal-title":"Neuromuscul Disord NMD"},{"issue":"5","key":"10.1016\/j.rdc.2025.07.004_bib70","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1212\/WNL.0000000000003568","article-title":"Sarcoplasmic MxA expression: a valuable marker of dermatomyositis","volume":"88","author":"Uruha","year":"2017","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.rdc.2025.07.004_bib71","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/mus.28066","article-title":"Myxovirus resistance protein A (MxA) expression in myositides: sarcoplasmic expression is common in both dermatomyositis and lupus myositis","volume":"69","author":"Xing","year":"2024","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1016\/j.rdc.2025.07.004_bib72","doi-asserted-by":"crossref","first-page":"e739","DOI":"10.1212\/WNL.0000000000013176","article-title":"Dermatomyositis: muscle pathology according to antibody subtypes","volume":"98","author":"Tanboon","year":"2022","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.rdc.2025.07.004_bib73","article-title":"Muscle pathology of antisynthetase syndrome according to antibody subtypes","volume":"33","author":"Tanboon","year":"2023","journal-title":"Brain Pathol Zurich Switz"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X25000511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X25000511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:22:44Z","timestamp":1761592964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X25000511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0889857X25000511"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2025.07.004","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic Evaluation for Myositis and Their Pitfalls","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2025.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}